Skip to content

The effect of methotexate and hydroxychloroquine on lichen planopilaris

Clinical trial of comparison of methotrexate versus hydroxychloroquine on disease activity index in patients with lichen planopilaris

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015062822959N1
Enrollment
24
Registered
2015-08-19
Start date
2015-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lichen planopilaris. Follicular lichen planus

Interventions

Intervention 1: Methotrexate (15 mg/week orally, in one day) will be administered in one group (15 patients) and for 6 months. Intervention 2: Hydroxychloroquine sulfate (Two tablets daily that is equ
Treatment - Drugs
Methotrexate (15 mg/week orally, in one day) will be administered in one group (15 patients) and for 6 months.
Hydroxychloroquine sulfate (Two tablets daily that is equivalent to 400 mg) administered in the other group (14 patients) for 6 months

Sponsors

Vice Chancellor for Research, Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Scalp involvement> 10% and no response to the previous 3-month topical or 6-month systemic medications; In the case of local involvement ( 2 times of upper limit of normal; and positive viral hepatic markers. Withdrawal criteria include no show up in follow-up visits; discontinuing the medication by patient; administration of another immunosuppressive or topical medication by other physician.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lichen planopilaris activity index. Timepoint: Before and after intervention. Method of measurement: Checklist.;Standardized global photpgraphy. Timepoint: Before and after intervention. Method of measurement: Based on scoring by two deramtologist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mina Saber

Isfahan University of Medical Sciences and Health Services

m_saber@mail.mui.ac.ir+98 31 3669 5414

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026